| Literature DB >> 31773075 |
Blake N Shultz1, Anoop R Galivanche1, Taylor D Ottesen1, Patawut Bovonratwet1, Jonathan N Grauer1.
Abstract
INTRODUCTION: National databases, such as the National Surgical Quality Improvement Program (NSQIP) database, are frequently used for total hip arthroplasty (THA) studies. NSQIP variables and the population included in the database have evolved over time. These changes may influence the results of studies using different periods of data.Entities:
Year: 2019 PMID: 31773075 PMCID: PMC6855500 DOI: 10.5435/JAAOSGlobal-D-19-00108
Source DB: PubMed Journal: J Am Acad Orthop Surg Glob Res Rev ISSN: 2474-7661
Comparison of Demographics Between the 2005 to 2010 and 2011 to 2015 Era Groups in the Total Hip Arthroplasty Cohort
| Variable | Total | 2005-2010 Group | 2011-2015 Group | |
| No. of patients | 102,411 | 8098 | 94,313 | |
| Age (yr), mean ± SD | 64.93 ± 11.83 | 65.22 ± 12.41 | 64.91 ± 11.78 | 0.0232 |
| Race (%) | ||||
| White | 77.03 | 81.64 | 76.63 | |
| Black | 7.10 | 6.98 | 7.11 | |
| Hispanic | 2.90 | 4.10 | 2.79 | |
| Other or unknown | 12.97 | 7.29 | 13.46 | |
| Male sex (%) | 44.75 | 44.47 | 44.77 | 0.601 |
| BMI (kg/m2), mean ± SD | 30.07 ± 6.46 | 29.95 ± 6.67 | 30.08 ± 6.44 | 0.0645 |
| Morbid obesity (%) | 7.22 | 7.42 | 7.20 | 0.456 |
| Smoking history (%) | 13.40 | 14.00 | 13.35 | 0.097 |
| Alcohol use[ | 0.53 | 3.49 | 0.27 | |
| ASA class (mean ± SD) | 2.39 ± 0.60 | 2.43 ± 0.60 | 2.39 ± 0.60 | |
| ASA class ≥ 3 (%) | 41.61 | 44.48 | 41.37 | |
| Diabetes (%) | ||||
| Insulin | 2.73 | 2.85 | 2.72 | |
| Non-insulin | 8.81 | 8.75 | 8.82 | |
| No | 88.45 | 88.39 | 88.46 | |
| Hypertension (%) | 56.58 | 59.95 | 56.29 | |
| Pulmonary comorbidity (%) | 4.13 | 4.51 | 4.10 | 0.077 |
| Cardiac comorbidity[ | 1.65 | 10.15 | 0.92 | |
| Congestive heart failure (%) | 0.34 | 0.23 | 0.35 | 0.095 |
| Renal comorbidity (%) | 0.28 | 0.26 | 0.29 | 0.674 |
| Neurologic comorbidity[ | 0.74 | 5.68 | 0.32 | |
| Steroid use | 3.70 | 3.17 | 3.75 | 0.009 |
| Bleeding disorder (%) | 2.52 | 2.73 | 2.51 | 0.218 |
| Functional status (%) | ||||
| Independent | 97.30 | 92.91 | 97.68 | |
| Partially dependent | 2.57 | 6.72 | 2.22 | |
| Totally dependent | 0.12 | 0.37 | 0.10 |
Alcohol use = 2 drinks per day or more in the two weeks prior to admission. ASA = American Society of Anesthesiologists, BMI = body mass index
Variable no longer collected in 2014 and 2015.
Values in bold indicate significance (P < 0.003 based on Bonferroni correction).
Comparison of Surgical Time Between the 2005 to 2010 and 2011 to 2015 Era Groups in the Total Hip Arthroplasty Cohort
| Variable | Total | 2005-2010 Group | 2011-2015 Group | |
| No. of patients | 102,411 | 8098 | 94,313 | |
| Surgical time (mean ± SD) | 94.12 ± 41.12 | 98.25 ± 42.69 | 93.76 ± 40.96 |
Value in bold indicates significance (P < 0.05).
Comparison of Postoperative Variables and Adverse Events Between the 2005 to 2010 and 2011 to 2015 Era Groups in the Total Hip Arthroplasty Cohort
| Variable | Total | 2005-2010 Group | 2011-2015 Group | |
| No. of patients | 102,411 | 8098 | 94,313 | |
| Wound infection (%) | 1.00 | 1.16 | 0.99 | 0.135 |
| Pneumonia (%) | 0.38 | 0.46 | 0.38 | 0.253 |
| Unplanned intubation (%) | 0.22 | 0.35 | 0.21 | 0.011 |
| Pulmonary embolism (%) | 0.27 | 0.31 | 0.27 | 0.514 |
| Ventilation in >48 hours (%) | 0.10 | 0.12 | 0.09 | 0.418 |
| Progressive renal insufficiency (%) | 0.11 | 0.17 | 0.10 | 0.077 |
| Acute renal failure (%) | 0.05 | 0.05 | 0.05 | 0.892 |
| UTI (%) | 1.10 | 1.68 | 1.05 | |
| CVA/stroke with neuro deficit (%) | 0.10 | 0.19 | 0.09 | 0.008 |
| Cardiac arrest (%) | 0.09 | 0.14 | 0.08 | 0.129 |
| Myocardial infarction (%) | 0.24 | 0.20 | 0.24 | 0.444 |
| Blood transfusion (%) | 11.22 | 7.50 | 11.54 | |
| DVT (%) | 0.42 | 0.58 | 0.41 | 0.019 |
| Sepsis (%) | 0.30 | 0.61 | 0.28 | |
| Septic shock (%) | 0.07 | 0.15 | 0.07 | 0.011 |
| 30-day mortality (%) | 0.18 | 0.28 | 0.17 | 0.024 |
| Wound dehiscence (%) | 0.12 | 0.11 | 0.12 | 0.869 |
| Return to the OR (%) | 2.05 | 1.90 | 2.06 | 0.334 |
| LOS (mean ± SD) | 3.03 ± 3.75 | 3.60 ± 2.46 | 2.98 ± 3.84 | |
| Extended LOS[ | 2.42 | 3.89 | 2.29 |
CVA = cerebrovascular accident, DVT = deep vein thrombosis, LOS = length of stay, OR = operating room, UTI = urinary tract infection
Extended LOS is defined as an LOS greater than or equal to 7 days.
Values in bold indicate significance (P < 0.003 based on Bonferroni correction).
Association of Increasing Age With Perioperative Outcomes for the 2005 to 2010 and 2011 to 2015 Era Groups
| Variable | 2005-2010 Group | 2011-2015 Group | ||
| Odds ratio (99.50% CI) | Odds ratio (99.50% CI) | |||
| UTI | ||||
| LOS | ||||
| 30-day mortality | 1.057 (0.971–1.150) | 0.065 | ||
| Pneumonia | 1.035 (0.980–1.092) | 0.073 | ||
| DVT/thrombophlebitis | 1.020 (0.978–1.063) | 0.182 | ||
| Unplanned reintubation | 1.016 (0.972–1.063) | 0.304 | ||
| Extended LOS[ | 1.013 (0.996–1.030) | 0.029 | ||
| Sepsis | 1.012 (0.974–1.051) | 0.385 | 1.010 (0.990–1.030) | 0.157 |
| Transfusion | 1.010 (0.998–1.021) | 0.014 | ||
| Surgical site infection | 1.001 (0.973–1.031) | 0.906 | 0.999 (0.991–1.009) | 0.924 |
| Return to the OR | 0.986 (0.964–1.008) | 0.069 | ||
DVT = deep vein thrombosis, LOS = length of stay, OR = operating room
Extended LOS is defined as an LOS greater than or equal to 7 days.
Values in bold indicate significance (P < 0.005 based on Bonferroni correction).
Figure 1Illustration of the association of increasing age with perioperative complications from 2005 to 2010 (n = 8098). Relative risk is for age as a continuous variable. CI = confidence interval, DVT = deep vein thrombosis, OR = operating room
Figure 2Illustration of the association of increasing age with perioperative complications from 2011 to 2015 (n = 94,313). Relative risk is for age as a continuous variable. CI = confidence interval, DVT = deep vein thrombosis, OR = operating room